Abstract
Rationale
The psychostimulant d-amphetamine, the D2/3 dopamine receptor agonist quinpirole and the 5-HT2 receptor agonist 2,5-dimethoxy-4-iodoamphetamine (DOI) have similar effects on free-operant timing behaviour. There is evidence that tolerance develops to the effects of psychostimulants on timing performance during chronic treatment; this tolerance is generally attributed to behavioural adaptation rather than to pharmacological desensitisation. There have been no previous investigations of tolerance to the effect of DOI on free-operant timing behaviour.
Objective
To demonstrate tolerance to DOI’s effect on timing performance and to examine the nature of this tolerance.
Materials and methods
Rats were trained under the free-operant psychophysical procedure to press two levers (A and B) in 80-s trials in which reinforcement was provided intermittently for responding on A in the first half and B in the second half of the trial. Percent responding on B (%B) was recorded in successive 8-s epochs of the trials; logistic functions were fitted to the data from each rat for the derivation of timing indices (T 50 [time corresponding to %B = 50]; Weber fraction).
Results
In experiment 1, DOI (0.25 mg kg−1) reduced T 50 compared to vehicle; tolerance to this effect was seen after repeated daily treatments with DOI if the rats were exposed to behavioural training during the period of treatment but not if the repeated treatments took place during a ‘holiday’ from behavioural training. In experiment 2, repeated treatment with DOI resulted in tolerance to the effect of DOI on T 50 and cross-tolerance to the effect of d-amphetamine (0.4 mg kg−1), but no cross-tolerance was seen to the effect of quinpirole (0.08 mg kg−1).
Conclusions
The results indicate that behavioural adaptation is involved in the development of tolerance to DOI’s effect on timing. The finding of cross-tolerance to d-amphetamine but not to quinpirole suggests that the reduction of T 50 in the free-operant psychophysical procedure may be brought about by two distinct pharmacological mechanisms, one activated by DOI and d-amphetamine, and the other by quinpirole.
Similar content being viewed by others
Notes
Most drugs acting at D1 dopamine receptors do not discriminate between D1 and D5 dopamine receptors and are therefore more precisely designated as D1-like receptor agonists and antagonists. Similarly, most drugs acting at D2 receptors do not discriminate between D2, D3 and D4 receptors and are therefore designated as D2-like receptor agonists and antagonists (Seeman and van Tol 1994; Strange 2001). Throughout this paper, for the sake of simplicity, they are referred to as D1 and D2 receptor agonists and antagonists.
For the purposes of this paper, the term tolerance is used, without any mechanistic or theoretical connotations, to refer to the phenomenon of a declining effect of a drug during chronic treatment. We distinguish between two processes, not necessarily mutually exclusive, which may contribute to tolerance: pharmacological desensitization, which occurs independently of any behavioural training (e.g. receptor down-regulation or enzyme induction), and behavioural adaptation, which requires exposure to a behavioural contingency during continued drug treatment. Hypothetical mechanisms underlying behavioural adaptation include the postulated ‘blunting’ of the hedonic quality of reinforcers during chronic treatment with conventional antipsychotics (Wise 1982) and the postulated ‘recalibration’ of the hypothetical internal clock during chronic treatment with drugs that are believed to alter the period of the pacemaker (Meck 1996).
References
Alexander M, Rothman RB, Baumann MH, Endres CJ, Brasic JR, Wong DF (2005) Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis. Synapse 56:94–99
Al-Zahrani SSA, Ho M-Y, Velazquez Martinez DN, Lopez Martinez M, Bradshaw CM, Szabadi E (1996) Effect of destruction of the 5-hydroxytryptaminergic pathways on behavioural timing and ‘switching’ in a free-operant psychophysical procedure. Psychopharmacology 127:346–352
Anji A, Kumari M, Sullivan Hanley NR, Bryan GL, Hensler JG (2000) Regulation of 5-HT2A receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin. Neuropharmacology 39:1996–2005
Asgari K, Body S, Zhang Z, Fone KFC, Bradshaw CM, Szabadi E (2006) Effects of 5-HT1A and 5-HT2A receptor stimulation on temporal differentiation performance in the fixed-interval peak procedure. Behav Processes 71:250–257
Bayley PJ, Bentley GD, Dawson GR (1998) The effects of selected antidepressant drugs on timing behaviour in rats. Psychopharmacology 136:114–122
Bizo LA, White KG (1994a) The behavioral theory of timing: reinforcer rate determines pacemaker rate. J Exp Anal Behav 61:19–33
Bizo LA, White KG (1994b) Pacemaker rate and the behavioral theory of timing. J Exp Psychol Anim Behav Process 20:308–321
Body S, Kheramin S, Mobini S, Ho M-Y, Velazquez-Martinez DN, Bradshaw CM, Szabadi E (2002) Antagonism by WAY-100635 of the effects of 8-OH-DPAT on performance on a free-operant timing schedule in intact and 5-HT-depleted rats. Behav Pharmacol 13:514–603
Body S, Kheramin S, Ho M-Y, Miranda F, Bradshaw CM, Szabadi E (2003) Effects of a 5-HT2 receptor agonist, DOI (2,5-dimethoxy-4-iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule. Behav Pharmocol 14:599–607
Body S, Kheramin S, Ho M-Y, Miranda F, Bradshaw CM, Szabadi E (2004) Effects of fenfluramine on free-operant timing behaviour: evidence for involvement of 5-HT2A receptors. Psychopharmacology 176:154–165
Body S, Asgari K, Cheung THC, Bezzina G, Fone KFC, Glennon JC, Bradshaw CM, Szabadi E (2006a) Evidence that the effect of 5-HT2 receptor stimulation on temporal differentiation is not mediated by receptors in the dorsal striatum. Behav Proc 71:258–267
Body S, Cheung THC, Bezzina G, Asgari K, Fone KCF, Glennon JC, Bradshaw CM, Szabadi E (2006b) Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behaviour: interaction between D1 and 5-HT2A receptors. Psychopharmacology 189:331–343
Buhusi CV (2003) Dopaminergic mechanisms of interval timing and attention. In: Meck WH (ed) Functional and neural mechanisms of interval timing. CRC Press, Boca Raton, pp 317–338
Buhusi CV, Meck WH (2002) Differential effects of methamphetamine and haloperidol on the control of an internal clock. Behav Neurosci 116:291–297
Burris KD, Pacheco MA, Filtz TM, Kung M-P, Kung HF, Molinoff PB (1995) Lack of discrimination by agonists for D2 and D3 dopamine receptors. Neuropsychopharmacology 12:335–345
Catania AC (1970) Reinforcement schedules and psychophysical judgements: a study of some temporal properties of behavior. In: Schoenfeld WN (ed) The theory of reinforcement schedules. Appleton, New York, pp 1–42
Catania AC, Reynolds GS (1968) A quantitative analysis of the responding maintained by interval schedules of reinforcement. J Exp Anal Behav 11(Suppl):327–383
Cheung THC, Bezzina G, Asgari K, Body S, Fone KFC, Bradshaw CM, Szabadi E (2006) Evidence for a role of D1 dopamine receptors in d-amphetamine’s effect on timing behaviour in the free-operant psychophysical procedure. Psychopharmacology 185:378–388
Chiang TJ, Al-Ruwaitea ASA, Ho MY, Bradshaw CM, Szabadi E (1998) The influence of ‘switching’ on the psychometric function in the free-operant psychophysical procedure. Behav Processes 44:197–209
Chiang TJ, Al-Ruwaitea AS, Ho MY, Bradshaw CM, Szabadi E (1999) Effect of central 5-hydroxytryptamine depletion on performance in the free-operant psychophysical procedure: facilitation of switching, but no effect on temporal differentiation of responding. Psychopharmacology 143:166–173
Chiang TJ, Al-Ruwaitea AS, Mobini S, Ho MY, Bradshaw CM, Szabadi E (2000a) The effect of d-amphetamine on performance on two operant timing schedules. Psychopharmacology 150:170–184
Chiang TJ, Al-Ruwaitea AS, Mobini S, Ho MY, Bradshaw CM, Szabadi E (2000b) Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on performance on two operant timing schedules. Psychopharmacology 151:379–391
Damjanoska KJ, Heidenreich BA, Kindel GH, D’Souza DN, Zhang Y, Garcia F, Battaglia G, Wolf WA, Van de Kar LD, Muma NA (2004) Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus. J Pharmacol Exp Ther 309:1043–1050
Eckerman DA, Segbefia D, Manning S, Breese GS (1987) Effects of methylphenidate and d-amphetamine on timing in the rat. Pharmacol Biochem Behav 27:513–515
Frederick DL, Allen JD (1996) Effects of selective dopamine D1- and D2-agonists and antagonists on timing performance in rats. Pharmacol Biochem Behav 53:759–764
Gehlert DR, Gackenheimer SL, Seeman P, Schaus J (1992) Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain. Eur J Pharm 211:189–194
Gibbon J, Malapani C, Dale CL, Gallistel C (1997) Toward a neurobiology of temporal cognition: advances and challenges. Curr Opin Neurobiol 7:170–184
Hinton SC, Meck WH (1997) How time flies: functional and neural mechanisms of interval timing. In: Bradshaw CM, Szabadi E (eds) Time and behaviour: psychological and neurobehavioural analyses. Elsevier, Amsterdam, pp 409–457
Ho MY, Velazquez-Martinez DN, Bradshaw CM, Szabadi E (2002) 5-Hydroxytryptamine and interval timing behaviour. Pharmacol Biochem Behav 71:773–785
Killeen PR, Fetterman JG (1988) A behavioral theory of timing. Psychol Rev 95:274–295
Killeen PR, Fetterman JG, Bizo LA (1997) Time’s causes. In: Bradshaw CM, Szabadi E (eds) Time and behaviour: psychological and neurobehavioural analyses. Elsevier, Amsterdam, pp 79–131
Kraemer PJ, Randall CK, Dose JM, Brown RW (1997) Impact of d-amphetamine on temporal estimation in pigeons tested with a production procedure. Pharmacol Biochem Behav 58:323–327
Lejeune H (1998) Switching or gating? The attentional challenge in cognitive models of psychological time. Behav Processes 44:127–145
Levant B, Grigoriadis DE, DeSouza EB (1992) Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain. J Pharm Exp Ther 262:929–935
Machado A, Guilhardi P (2000) Shifts in the psychometric function and their implications for models of timing. J Exp Anal Behav 74:25–54
Maricq AV, Roberts S, Church RM (1981) Methamphetamine and time estimation. J Exp Psychol Anim Behav Process 7:18–30
Matell MS, King GR, Meck WH (2004) Differential modulation of clock speed by the administration of intermittent versus continuous cocaine. Behav Neurosci 118:150–156
McKenna DJ, Nazarali A, Himeno A, Saavedra JM (1989) Chronic treatment with (±)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain. Neuropsychopharmacology 2:81–87
Meck WH (1996) Neuropharmacology of timing and time perception. Cogn Brain Res 3:227–242
Munoz A, Lopez-Real A, Labandeira-Garcia JL, Guerra MJ (2003) Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats. Exp Brain Res 153:92–99
Raiteri M, Bertollini A, Angelini F, Levi G (1975) d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol 34:189–195
Roberts S (1981) Isolation of an internal clock. J Exp Psychol Anim Behav Process 7:242–268
Roth BL, Palvimaki EP, Berry S, Khan N, Sachs N, Uluer A, Choudhary MS (1995) 5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation. J Pharmacol Exp Ther 275:1638–1646
Roth BL, Willins DL, Kristiansen K, Kroeze WK (1998) 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2c): where structure meets function. Pharmacol Ther 231:231–257
Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32–41
Sanger DJ, Depoortere R, Perrault G (1996) Evidence for a role for dopamine D3 receptors in the effects of dopamine agonists on operant behaviour in rats. Behav Pharmacol 7:477–482
Saulsgiver KA, McClure EA, Wynne CDL (2006) Effects of D-amphetamine on the behavior of pigeons exposed to the peak procedure. Behav Processes 71:268–285
Seeman P, van Tol HHM (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264–270
Smith RL, Barrett RJ, Sanders-Bush E (1999) Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor. Psychopharmacology 144:248–254
Strange PG (2001) Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol Rev 153:119–133
Stubbs DA (1976) Scaling of stimulus duration by pigeons. J Exp Anal Behav 26:15–25
Stubbs DA (1980) Temporal discrimination and a free-operant psychophysical procedure. J Exp Anal Behav 33:167–185
Wise RA (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 5:39–87
Zakay D, Block RA (1995) An attentional gate model of prospective time estimation. In: Richelle M, De Keyser V, d’Ydewalle G, Vandierendonck A (eds) Time and the dynamic control of behavior. University of Liège, Liège, pp 167–178
Zakay D, Block RA (1996) The role of attention in time estimation processes. In: Pastor MA, Artieda J (eds) Time, internal clocks and movement. Elsevier, Amsterdam, pp 143–164
Ziance RJ (1977) Specificity of amphetamine induced release of norepinephrine and serotonin from rat brain in vitro. Res Commun Chem Pathol Pharmacol 18:627–644
Acknowledgments
This work was supported by the BBSRC. We are grateful to Mrs. Victoria Bak for her skilled technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cheung, T.H.C., Bezzina, G., Body, S. et al. Tolerance to the effect of 2,5-dimethoxy-4-iodoamphetamine (DOI) on free-operant timing behaviour: interaction between behavioural and pharmacological mechanisms. Psychopharmacology 192, 521–535 (2007). https://doi.org/10.1007/s00213-007-0743-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-007-0743-x